Targeting Diabetes Prevention to More Disadvantaged Groups Improves Cost-Effectiveness: Implications of Inequality in Type 2 Diabetes From Theoretical Interventions

Jedidiah I Morton(Baker Heart and Diabetes Institute), Zanfina Ademi(Monash University)
Value in Health
February 15, 2023
10.1016/j.jval.2023.02.003
Cited by 5

Related Papers

Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
|The Lancet|2018|5k
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition
|The Lancet|2015|2k
Global, regional, and national levels and causes of maternal mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
|The Lancet|2014|1.7k
Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis
|BMJ|2021|809
Chronic Kidney Disease and Cerebrovascular Disease
|Stroke|2021|142